Brief: Repare Therapeutics - Steve Forte, Executive Vice President And Chief Financial Officer, Appointed As President, Chief Executive Officer And Director
March 31 (Reuters) - Repare Therapeutics Inc RPTX.O: REPARE THERAPEUTICS - STEVE FORTE, EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER, APPOINTED AS PRESIDENT, CHIEF EXECUTIVE OFFICER AND DIRECTOR REPARE THERAPEUTICS: LLOYD M. SEGAL RESIGNED AS PRESIDENT, CEO AND DIRECTOR REPARE THERAPEUTICS- EXPLORING STRATEGIC ALTERNATIVES AND PARTNERSHIPS ACROSS PORTFOLIO, INCLUDING FOR LUNRESERTIB & CAMONSERTIB Source text: ID:nBw4ccC3Qa Further company coverage: RPTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln